ESC Premium Access

Screening for atrial fibrillation in the primary health care setting

Congress Presentation

About the speaker

Doctor Faris Ghazal

Karolinska Institute, Stockholm (Sweden)
0 follower

11 more presentations in this session

How patient advocacy in partnership with community pharmacy can identify people at risk of AF in community pharmacy setting

Speaker: Mrs T. Lobban (Oxford, GB)


Benefits of active involvement of community pharmacists in know your pulse awareness campaign

Speaker: Mr S. Antoniou (London, GB)


lipid profile and incidence of atrial fibrillation: results from the Kailuan Study

Speaker: Doctor Y. Xia (Dalian, CN)


Prevalence rates of atrial fibrillation tentatively increased during and after the Great East Japan earthquake.

Speaker: Doctor K. Tamaki (Morioka, JP)


Risk for adverse outcome events according to paroxysmal vs. non-paroxysmal atrial fibrillation

Speaker: Doctor S. Blum (Basel, CH)


Access the full session

Poster session 5 - Demographics and screening

Speakers: Doctor F. Ghazal, Mrs T. Lobban, Mr S. Antoniou, Doctor Y. Xia, Doctor K. Tamaki...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb